Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Half Year Ended June 30, 2022
August 11, 2022 at 04:52 pm EDT
Energenesis Biomedical CO.,LTD. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 2.86 million compared to TWD 3.59 million a year ago. Net loss was TWD 100.35 million compared to TWD 53.9 million a year ago. Basic loss per share from continuing operations was TWD 1.51 compared to TWD 0.9 a year ago. Diluted loss per share was TWD 1.51 compared to TWD 0.9 a year ago.